US 10,485,883 · Application 15/433,322 · Granted Nov 26, 2019
US 10,485,883
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
Estimated expiration
September 30, 2024
Expired 739 days ago
Earliest effective filing
Sep 30, 2004
+ 20 years
Sep 30, 2024
PTA +0d
Sep 30, 2024
TD applied
Sep 30, 2024
Final
Sep 30, 2024
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- February 15, 2017
- Earliest effective filing
- September 30, 2004
- Issue date
- November 26, 2019
- PTA
- 0 days
- Base expiry (before PTA)
- September 30, 2024
September 30, 2004 + 20 years = September 30, 2024
- Continuation of application 15/227,418, filed Aug 3, 2016, issued as US 10,265,417
- Continuation of application 13/023,918, filed Feb 9, 2011
- Continuation of application 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
- National stage entry of application PCTUS2004028817, filed Sep 30, 2004
- National stage entry of application PCTUS2004028817, filed Sep 30, 2004
- Continuation of application 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
- National stage entry of application PCTUS2004028817, filed Sep 30, 2004
- Continuation of application 13/023,918, filed Feb 9, 2011
- Continuation of application 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
- National stage entry of application PCTUS2004028817, filed Sep 30, 2004
- PRO60/508,226 — Provisional — not used for base term
- PRO60/566,546 — Provisional — not used for base term
- PRO60/508,226 — Provisional — not used for base term
- PRO60/566,546 — Provisional — not used for base term
- PRO60/508,226 — Provisional — not used for base term
- PRO60/566,546 — Provisional — not used for base term
- PRO60/566,546 — Provisional — not used for base term
- PRO60/508,226 — Provisional — not used for base term
- PRO60/508,226 — Provisional — not used for base term
- PRO60/566,546 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to September 30, 2024
US 10,485,883· Application 15/433,322(from application 15/433,322)Capping patent
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
- Filing date
- Feb 15, 2017
- Earliest effective filing
- Sep 30, 2004
- Issue date
- Nov 26, 2019
- PTA
- 0 days
- Calculated expiration
- Sep 30, 2024
Continuation of 15/227,418, filed Aug 3, 2016, issued as US 10,265,417
Continuation of 13/023,918, filed Feb 9, 2011
Continuation of 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
National stage entry of PCTUS2004028817, filed Sep 30, 2004
National stage entry of PCTUS2004028817, filed Sep 30, 2004
Continuation of 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
National stage entry of PCTUS2004028817, filed Sep 30, 2004
Continuation of 13/023,918, filed Feb 9, 2011
Continuation of 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
National stage entry of PCTUS2004028817, filed Sep 30, 2004
Sep 30, 2004 + 20y = Sep 30, 2024
US 10,406,173· Application 15/862,999(from application 15/862,999)
Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
- Filing date
- Jan 5, 2018
- Earliest effective filing
- Feb 17, 2012
- Issue date
- Sep 10, 2019
- PTA
- 0 days
- Calculated expiration
- Feb 17, 2032
Divisional of 13/985,630, filed Aug 15, 2013, issued as US 9,884,071
National stage entry of PCTUS2012025550, filed Feb 17, 2012
National stage entry of PCTUS2012025550, filed Feb 17, 2012
Feb 17, 2012 + 20y = Feb 17, 2032
US 7,906,111· Application 10/573,600
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
- Filing date
- Mar 24, 2006
- Earliest effective filing
- Sep 30, 2004
- Issue date
- Mar 15, 2011
- PTA
- +473 days
- Calculated expiration
- Jan 16, 2026
National stage entry of PCTUS2004028817, filed Sep 30, 2004
Sep 30, 2004 + 20y + 473d PTA = Jan 16, 2026
US 10,265,417· Application 15/227,418(from application 15/227,418)
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
- Filing date
- Aug 3, 2016
- Earliest effective filing
- Sep 30, 2004
- Issue date
- Apr 23, 2019
- PTA
- 0 days
- Calculated expiration
- Sep 30, 2024
Continuation of 13/023,918, filed Feb 9, 2011
Continuation of 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
National stage entry of PCTUS2004028817, filed Sep 30, 2004
National stage entry of PCTUS2004028817, filed Sep 30, 2004
Continuation of 10/573,600, filed Mar 24, 2006, issued as US 7,906,111
National stage entry of PCTUS2004028817, filed Sep 30, 2004
Sep 30, 2004 + 20y = Sep 30, 2024
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 15/433,322 · US 10,485,883
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 10,485,883: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US10485883Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.